ACTINIUM PHARMACEUTICALS, INC. Interest Income (Expense), Net
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Interest Income (Expense), Net of $927.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-26.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2024-04-26
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2024-03-31 was $927.00K, a 69.47% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2023-12-31 was $1.02M, a 58.23% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2023-09-30 was $1.07M, a 230.77% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2023-06-30 was $461.00K, a 455.42% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for fiscal 2023 was $3.10M, a 185.37% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for fiscal 2022 was $1.09M, a 472.11% increase from fiscal 2021.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for fiscal 2021 was $190.00K, a 6.74% increase from fiscal 2020.
- ACTINIUM PHARMACEUTICALS, INC. interest income (expense), net for fiscal 2020 was $178.00K, a 3.49% increase from fiscal 2019.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 3 month as first filed | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 6 month as first filed | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 9 month as first filed | Interest Income (Expense), Net 12 month | Interest Income (Expense), Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $927.00K 10-Q · filed 2024-04-26 | $1.95M derived: sum of 2 quarters · filed 2024-04-26 | $3.02M derived: sum of 3 quarters · filed 2024-04-26 | $3.48M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2023-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.09M derived: sum of 2 quarters · filed 2024-03-29 | $2.56M derived: sum of 3 quarters · filed 2024-03-29 | $3.10M 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | $1.07M 10-Q · filed 2023-11-02 | $1.54M derived: sum of 2 quarters · filed 2023-11-02 | $2.08M 10-Q · filed 2023-11-02 | $2.73M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2023-06-30 | $461.00K 10-Q · filed 2023-08-14 | $1.01M 10-Q · filed 2023-08-14 | $1.65M derived: sum of 3 quarters · filed 2024-04-26 | $1.98M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2023-03-31 | $547.00K 10-Q · filed 2024-04-26 | $1.19M derived: sum of 2 quarters · filed 2024-04-26 | $1.52M derived: sum of 3 quarters · filed 2024-04-26 | $1.60M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2022-12-31 | $644.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $969.00K derived: sum of 2 quarters · filed 2024-03-29 | $1.05M derived: sum of 3 quarters · filed 2024-03-29 | $1.09M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $325.00K 10-Q · filed 2023-11-02 | $408.00K derived: sum of 2 quarters · filed 2023-11-02 | $443.00K 10-Q · filed 2023-11-02 | $481.00K derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $83.00K 10-Q · filed 2023-08-14 | $118.00K 10-Q · filed 2023-08-14 | $156.00K derived: sum of 3 quarters · filed 2023-08-14 | $202.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $35.00K 10-Q · filed 2023-05-15 | $73.00K derived: sum of 2 quarters · filed 2023-05-15 | $119.00K derived: sum of 3 quarters · filed 2023-05-15 | $173.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $84.00K derived: sum of 2 quarters · filed 2023-03-31 | $138.00K derived: sum of 3 quarters · filed 2023-03-31 | $190.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $46.00K 10-Q · filed 2022-11-14 | $100.00K derived: sum of 2 quarters · filed 2022-11-14 | $152.00K 10-Q · filed 2022-11-14 | $207.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $54.00K 10-Q · filed 2022-08-12 | $106.00K 10-Q · filed 2022-08-12 | $161.00K derived: sum of 3 quarters · filed 2022-08-12 | $234.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $52.00K 10-Q · filed 2022-05-13 | $107.00K derived: sum of 2 quarters · filed 2022-05-13 | $180.00K derived: sum of 3 quarters · filed 2022-05-13 | $217.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $128.00K derived: sum of 2 quarters · filed 2022-03-25 | $165.00K derived: sum of 3 quarters · filed 2022-03-25 | $178.00K 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | $73.00K 10-Q · filed 2021-11-12 | $110.00K derived: sum of 2 quarters · filed 2021-11-12 | $123.00K 10-Q · filed 2021-11-12 | $154.00K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $37.00K 10-Q · filed 2021-07-30 | $50.00K 10-Q · filed 2021-07-30 | $81.00K derived: sum of 3 quarters · filed 2021-07-30 | $134.00K derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2020-03-31 | $13.00K 10-Q · filed 2021-05-14 | $44.00K derived: sum of 2 quarters · filed 2021-05-14 | $97.00K derived: sum of 3 quarters · filed 2021-05-14 | $156.00K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $84.00K derived: sum of 2 quarters · filed 2021-03-31 | $143.00K derived: sum of 3 quarters · filed 2021-03-31 | $172.00K 10-K · filed 2021-03-31 | $172.39K 10-K · filed 2020-05-08 | |||
| 2019-09-30 | $53.00K 10-Q · filed 2020-10-23 | $53.05K 10-Q · filed 2019-11-12 | $112.00K derived: sum of 2 quarters · filed 2020-10-23 | $141.00K 10-Q · filed 2020-10-23 | $141.35K 10-Q · filed 2019-11-12 | $184.81K derived: sum of 4 quarters · filed 2020-10-23 | ||
| 2019-06-30 | $59.00K 10-Q · filed 2020-08-14 | $59.39K 10-Q · filed 2019-08-09 | $88.00K 10-Q · filed 2020-08-14 | $88.30K 10-Q · filed 2019-08-09 | $131.81K derived: sum of 3 quarters · filed 2020-08-14 | $180.99K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $29.00K 10-Q · filed 2020-06-29 | $28.91K 10-Q · filed 2019-05-10 | $72.81K derived: sum of 2 quarters · filed 2020-06-29 | $121.99K derived: sum of 3 quarters · filed 2020-06-29 | $172.02K derived: sum of 4 quarters · filed 2020-06-29 | |||
| 2018-12-31 | $43.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | $92.99K derived: sum of 2 quarters · filed 2020-05-08 | $143.02K derived: sum of 3 quarters · filed 2020-05-08 | $173.36K 10-K · filed 2020-05-08 | ||||
| 2018-09-30 | $49.18K 10-Q · filed 2019-11-12 | $99.21K derived: sum of 2 quarters · filed 2019-11-12 | $129.55K 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $50.03K 10-Q · filed 2019-08-09 | $80.37K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $30.34K 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | $5.43K 10-K · filed 2019-03-15 | |||||||
| 2016-12-31 | -$5.01K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |